News from orbusneich A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

01 Nov, 2017, 18:10 GMT Late-Breaking REDUCE Trial Data Demonstrate Non-inferiority of 3 vs 12 Months Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Treated With the COMBO[TM] Stent

One-year results from the REDUCE trial reported at TCT 2017 OrbusNeich has reported results from the REDUCE trial today in the Late-Breaking Clinical ...


30 Oct, 2017, 18:15 GMT OrbusNeich's COMBO™ Dual Therapy Stent Demonstrates Non-inferiority vs the Market Leading XIENCE™ Everolimus Eluting Stent

One-year results from the pivotal HARMONEE trial reported at TCT 2017 New results from the HARMONEE Japan/US Registration Trial, reported by...


23 Oct, 2017, 11:56 BST OrbusNeich Announces Schedule of Events at TCT 2017

Program to include late-breaking presentation of REDUCE clinical trial Data on more than 5,000 patients to be presented OrbusNeich, a global company...


06 Jun, 2017, 10:30 BST OrbusNeich Announces FDA Clearance, Launch of Coronary Dilatation Catheters

Announcement marks company's official entry into the US market OrbusNeich, a global company specializing in the provision of life-changing vascular...


11 Jan, 2017, 10:00 GMT OrbusNeich Expands Portfolio with a Next Generation Coronary Scoring Balloon

Launch of Scoreflex™ NC responds to cardiologists' need for a non-compliant scoring balloon in more resistant lesions OrbusNeich, a global company...


21 Nov, 2016, 10:30 GMT OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing

COMBO Plus: A combination of traditional drug-eluting stent (DES) components with the addition of a unique biological therapy and enhanced...


24 May, 2016, 10:06 BST OrbusNeich Expands Portfolio to Treat Peripheral Disease

The innovator of COMBO™,the world's first dual therapy stent, introduces catheters for lower limb and AV fistula intervention OrbusNeich, a global...


20 Jul, 2015, 11:26 BST OrbusNeich Announces Enrollment of First Patient in China Recovery Study

Study to enroll 436 patients at up to 20 sites throughout China OrbusNeich, a global company specializing in the provision of life-changing vascular...


18 May, 2015, 13:47 BST OrbusNeich Announces Initiation of HARMONEE Stent Study in US

Registration study to enroll 572 patients at up to 50 study locations in Japan and US OrbusNeich, a global company specializing in the provision of...


18 Sep, 2014, 09:00 BST Latest Data Shows OrbusNeich's COMBO™ Dual Therapy Stent has Excellent Healing Benefits

The world's first and only dual therapy stent Prof. Stephen W.L. Lee presented two-year optical coherence tomography (OCT) findings and three-year...


16 Jul, 2014, 10:00 BST First Patient Enrolment in MASCOT Registry Represents Major Milestone for COMBO™ Dual Therapy Stent and OrbusNeich's Clinical Programme

- 2,500-patient, 50-center study is the largest post-marketing registry on the safety and effectiveness of the COMBO Stent OrbusNeich today announced ...


23 May, 2014, 08:00 BST OrbusNeich Releases Long-term Data for World's First and Only Dual Therapy Stent

COMBO™ Dual Therapy Stent shown to actively promote rapid endothelialization and deliver long-term, true vessel healing OrbusNeich today announced...


24 Apr, 2014, 10:42 BST OrbusNeich Names B. Wayne Johnson President and Chief Operating Officer and Expands Board of Directors

OrbusNeich today announced the appointment of B. Wayne Johnson as president and chief operating officer and the expansion of its board of directors...


28 Mar, 2014, 13:00 GMT Patient Enrollment Completed in Multicenter European REMEDEE Registry of OrbusNeich's COMBO Dual Therapy Stent™

OrbusNeich today announced the completion of enrollment in the prospective, multicenter, all-comers REMEDEE Registry (Multicenter, Prospective,...


26 Feb, 2014, 09:00 GMT OrbusNeich Initiates HARMONEE Study in Japan to Evaluate the COMBO™ Dual Therapy Stent

OrbusNeich today announced that patient enrollment has been initiated in Japan in the pivotal clinical trial of the COMBO Dual Therapy Stent™ (COMBO...


29 Oct, 2013, 22:19 GMT OrbusNeich's COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

OrbusNeich today announced that new clinical data presented at TCT 2013 show durable outcomes as well as excellent early healing and optimal...


22 Oct, 2013, 15:00 BST Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

OrbusNeich today announced that clinical data for the COMBO Dual Therapy Stent will be presented at Transcatheter Cardiovascular Therapeutics (TCT)...


06 Aug, 2013, 14:30 BST First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent™ in Routine Practice

Patient enrollment has been initiated in a post-market registry for the COMBO Dual Therapy Stent to evaluate its long-term safety and performance in...


21 Mar, 2011, 07:00 GMT OrbusNeich Files Lawsuit Against Dr. Pavel Cervinka for Defamation

OrbusNeich today announced that it has filed a lawsuit in the Netherlands against Dr. Pavel Cervinka and Masaryk Hospital in Usti nad Labem, Czech...